Download PDF
Horm Metab Res 2016; 48(05): 306-311
DOI: 10.1055/s-0035-1565183
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Fertility and Pregnancy in Primary Adrenal Insufficiency in Germany

H. Remde
1   Clinical Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, Berlin, Germany
,
K. Zopf
1   Clinical Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, Berlin, Germany
,
J. Schwander
2   Endocrinology in Charlottenburg, Berlin, Germany
,
M. Quinkler
1   Clinical Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, Berlin, Germany
2   Endocrinology in Charlottenburg, Berlin, Germany
› Author Affiliations
Further Information

Publication History

received 18 September 2015

accepted 18 October 2015

Publication Date:
11 February 2016 (online)

Also available at
    Permissions and Reprints

Abstract

Autoimmune adrenalitis (AA) and congenital adrenal hyperplasia (CAH) are the most common reasons for acquired and monogenetic primary adrenal insufficiency. Both concern women in their fertile years. The aim of the work was to examine fertility rates, pregnancy outcome, and children’s characteristics in AA and CAH patients in 2 German endocrine centers. One hundred and fifty-eight women were contacted. Thirty-nine patients with CAH due to 21-hydroxlase deficiency and 54 AA patients agreed and were included. Information about course and outcome of pregnancies was obtained by questionnaire and telephone interview. Fertility rates were calculated and compared to expected values from the German general population. Twelve CAH patients (30.8%) had 25 pregnancies, which resulted in 16 children. In AA patients, 93 pregnancies in 42 women (75%) were reported resulting in 73 childbirths. Fertility rates were normal in nonclassic CAH and in AA-only patients, but significantly reduced in classic CAH and autoimmune polyendocrine syndrome type 2 (APS-2). Rates of miscarriages were high in all CAH (36%) and APS-2 (22%) patients. The majority of children in both groups were born at term, but rates of cesarean section were elevated in classic CAH and in AA patients<5 years before or after diagnosis. Children born to CAH patients weighed significantly less than expected and 33.3% of them were born small for gestational age. Fertility seems not to be reduced in general, but specific in classic CAH and APS 2 patients. Nevertheless all CAH and AA patients seem to be at risk of miscarriages and cesarean section.

Key words

congenital adrenal hyperplasia - APS - cesarean section - miscarriage
 

  • References

  • 1 Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. The Lancet 2014; 383: 2152-2167
    CrossrefPubMedGoogle Scholar
  • 2 Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216-226
    CrossrefPubMedGoogle Scholar
  • 3 White PC, Speiser PW. Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency 1. Endocr Rev 2000; 21: 245-291
    CrossrefPubMedGoogle Scholar
  • 4 Odenwald B, Dörr H-G, Bonfig W, Schmidt H, Fingerhut R, Wildner M, Nennstiel-Ratzel U. Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria. Klin Pädiatr 2015; 227: 278-283
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Moura-Massari VO, Bugano DDG, Marcondes JAM, Gomes LG, Mendonca BB, Bachega TASS. CYP21A2 Genotypes do not Predict the Severity of Hyperandrogenic Manifestations in the Nonclassical Form of Congenital Adrenal Hyperplasia. Horm Metab Res 2013; 45: 301-307
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Kamrath C, Hartmann MF, Wudy SA. Androgen Synthesis in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Horm Metab Res 2013; 45: 86-91
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Lekarev O, New MI. Adrenal disease in pregnancy. Best Pract Res Clin Endocrinol Metab 2011; 25: 959-973
    CrossrefPubMedGoogle Scholar
  • 8 Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa Gil F, Loeffler M, Ventz M, Hinz A, Beuschlein F, Allolio B, Reincke M, Quinkler M. Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patients with primary adrenal insufficiency: Quality of life in adult CAH patients. Clin Endocrinol (Oxf) 2011; 74: 166-173
    CrossrefPubMedGoogle Scholar
  • 9 Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, Nordenskjöld A, Frisén L, Nordenström A. Suboptimal Psychosocial Outcomes in Patients With Congenital Adrenal Hyperplasia: Epidemiological Studies in a Nonbiased National Cohort in Sweden. J Clin Endocrinol Metab 2014; 99: 1425-1432
    CrossrefPubMedGoogle Scholar
  • 10 Løvås K, Loge JH, Husebye ES. Subjective health status in Norwegian patients with Addison’s disease. Clin Endocrinol (Oxf) 2002; 56: 581-588
    CrossrefPubMedGoogle Scholar
  • 11 Björnsdottir S, Cnattingius S, Brandt L, Nordenström A, Ekbom A, Kämpe O, Bensing S. Addison’s Disease in Women Is a Risk Factor for an Adverse Pregnancy Outcome. J Clin Endocrinol Metab 2010; 95: 5249-5257
    CrossrefPubMedGoogle Scholar
  • 12 Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K. Sexuality and Fertility in Women with Addison’s Disease. J Clin Endocrinol Metab 2010; 95: 4354-4360
    CrossrefPubMedGoogle Scholar
  • 13 Krone N, Wachter I, Stefanidou M, Roscher AA, Schwarz HP. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001; 55: 523-529
    CrossrefPubMedGoogle Scholar
  • 14 Hagenfeldt K, Janson PO, Holmdahl G, Falhammar H, Filipsson H, Frisen L, Thoren M, Nordenskjold A. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23: 1607-1613
    CrossrefPubMedGoogle Scholar
  • 15 Casteràs A, De Silva P, Rumsby G, Conway GS. Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin Endocrinol (Oxf) 2009; 70: 833-837
    CrossrefPubMedGoogle Scholar
  • 16 Bidet M, Bellanné-Chantelot C, Galand-Portier M-B, Golmard J-L, Tardy V, Morel Y, Clauin S, Coussieu C, Boudou P, Mowzowicz I, Bachelot A, Touraine P, Kuttenn F. Fertility in Women with Nonclassical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 2010; 95: 1182-1190
    CrossrefPubMedGoogle Scholar
  • 17 Krone N, Braun A, Roscher AA, Knorr D, Schwarz HP. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000; 85: 1059-1065
    CrossrefPubMedGoogle Scholar
  • 18 Rivkees SA, Crawford JD. Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth. Pediatrics 2000; 106: 767-773
    CrossrefPubMedGoogle Scholar
  • 19 Caldato MC, Fernandes VT, Kater CE. One-year clinical evaluation of single morning dose prednisolone therapy for 21-hydroxylase deficiency. Arq Bras Endocrinol Metabol 2004; 48: 705-712
    CrossrefPubMedGoogle Scholar
  • 20 Witchel SF. Management of CAH during pregnancy: optimizing outcomes. Curr Opin Endocrinol Diabetes Obes 2012; 19: 489-496
    CrossrefPubMedGoogle Scholar
  • 21 Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HFL, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4133-4160
    CrossrefPubMedGoogle Scholar
  • 22 Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting A-L, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-115
    CrossrefPubMedGoogle Scholar
  • 23 Pötzsch O. Cohort fertility: A comparison of the results of the official birth statistics and of the Microcensus survey 2008. Comp Popul Stud 2010; 35
    PubMedGoogle Scholar
  • 24 Voigt M, Fusch C, Olbertz D, Hartmann K, Rochow N, Renken C, Schneider KTM. Analysis of the Neonatal Collective in the Federal Republic of Germany 12th Report: Presentation of Detailed Percentiles for the Body Measurement of Newborns. Geburtshilfe Frauenheilkd 2006; 66: 956-970
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Jääskeläinen J, Hippeläinen M, Kiekara O, Voutilainen R. Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand 2000; 79: 687-692
    PubMedGoogle Scholar
  • 26 Moran C, Azziz R, Weintrob N, Witchel SF, Rohmer V, Dewailly D, Marcondes JAM, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TAS, Escobar-Morreale HF, Carmina E, Fruzzetti F, Kelestimur F. Reproductive Outcome of Women with 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia. J Clin Endocrinol Metab 2006; 91: 3451-3456
    CrossrefPubMedGoogle Scholar
  • 27 Meyer-Bahlburg HFL, Dolezal C, Baker SW, New MI. Sexual Orientation in Women with Classical or Non-classical Congenital Adrenal Hyperplasia as a Function of Degree of Prenatal Androgen Excess. Arch Sex Behav 2008; 37: 85-99
    CrossrefPubMedGoogle Scholar
  • 28 Creighton SM, Minto CL, Steele SJ. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. The Lancet 2001; 358: 124-125
    CrossrefPubMedGoogle Scholar
  • 29 Crouch NS, Liao LM, Woodhouse CRJ, Conway GS, Creighton SM. Sexual Function and Genital Sensitivity Following Feminizing Genitoplasty for Congenital Adrenal Hyperplasia. J Urol 2008; 179: 634-638
    PubMedGoogle Scholar
  • 30 Nordenskjöld A, Holmdahl G, Frisén L, Falhammar H, Filipsson H, Thorén M, Janson PO, Hagenfeldt K. Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia. J Clin Endocrinol Metab 2008; 93: 380-386
    CrossrefPubMedGoogle Scholar
  • 31 Bachelot A, Plu-Bureau G, Thibaud E, Laborde K, Pinto G, Samara D, Nihoul-Fékété C, Kuttenn F, Polak M, Touraine P. Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Horm Res 2007; 67: 268-276
    CrossrefPubMedGoogle Scholar
  • 32 Hoepffner W, Schulze E, Bennek J, Keller E, Willgerodt H. Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity. Fertil Steril 2004; 81: 1314-1321
    CrossrefPubMedGoogle Scholar
  • 33 Lo JC, Schwitzgebel VM, Tyrrell JB, Fitzgerald PA, Kaplan SL, Conte FA, Grumbach MM. Normal Female Infants Born of Mothers with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. J Clin Endocrinol Metab 1999; 84: 930-936
    PubMedGoogle Scholar
  • 34 Reynolds RM, Seckl JR. Antenatal Glucocorticoid Treatment: Are We Doing Harm to Term Babies?. J Clin Endocrinol Metab 2012; 97: 3457-3459
    CrossrefPubMedGoogle Scholar
  • 35 Alexander N, Rosenlöcher F, Stalder T, Linke J, Distler W, Morgner J, Kirschbaum C. Impact of Antenatal Synthetic Glucocorticoid Exposure on Endocrine Stress Reactivity in Term-Born Children. J Clin Endocrinol Metab 2012; 97: 3538-3544
    CrossrefPubMedGoogle Scholar
  • 36 Sjöberg L, Pitkäniemi J, Haapala L, Kaaja R, Tuomilehto J. Fertility in people with childhood-onset type 1 diabetes. Diabetologia 2013; 56: 78-81
    CrossrefPubMedGoogle Scholar
  • 37 Wiebe JC, Santana A, Medina-Rodríguez N, Hernández M, Nóvoa J, Mauricio D, Wägner AM. Fertility is reduced in women and in men with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium (T1DGC). Diabetologia 2014; 57: 2501-2504
    CrossrefPubMedGoogle Scholar
  • 38 Krassas GE, Poppe K, Glinoer D. Thyroid Function and Human Reproductive Health. Endocr Rev 2010; 31: 702-755
    CrossrefPubMedGoogle Scholar
  • 39 Reato G, Morlin L, Chen S, Furmaniak J, Smith BR, Masiero S, Albergoni MP, Cervato S, Zanchetta R, Betterle C. Premature Ovarian Failure in Patients with Autoimmune Addison’s Disease: Clinical, Genetic, and Immunological Evaluation. J Clin Endocrinol Metab 2011; 96: E1255-E1261
    CrossrefPubMedGoogle Scholar
  • 40 Falorni A, Brozzetti A, Aglietti MC, Esposito R, Minarelli V, Morelli S, Sbroma Tomaro E, Marzotti S. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency. Clin Endocrinol (Oxf) 2012; 77: 453-458
    CrossrefPubMedGoogle Scholar
  • 41 Brent F. Addison’s disease and pregnancy. Am J Surg 1950; 79: 645-652
    CrossrefPubMedGoogle Scholar
  • 42 Fux Otta C, Szafryk de Mereshian P, Iraci GS, Ojeda de Pruneda MR. Pregnancies associated with primary adrenal insufficiency. Fertil Steril 2008; 90: e1199.e17-e1199.e20
    CrossrefPubMedGoogle Scholar
  • 43 Andersen A-MN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000; 320: 1708-1712
    CrossrefPubMedGoogle Scholar